Loss to follow-up among adults with drug-resistant TB in Papua New Guinea
Public Health Action · 2024-09 · 14 (3) · 85-90
DOI: 10.5588/pha.24.0004 ↗At a glance
Journal article in Public Health Action, published online on 2024-09-01. Written by F Charles and 6 co-authors. Institution: The Burnet Institute, Port Moresby, Papua New Guinea (PNG). Cited 5 times so far (Crossref); 24 references. The full text is freely available in PubMed Central.
Abstract (original language)
SETTING Multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB) is now endemic in the National Capital District (NCD), Papua New Guinea. Loss to follow-up (LTFU) is a challenge. OBJECTIVE To evaluate and identify risk factors for LTFU, including pre-treatment LTFU, in adults with MDR/RR-TB at Port Moresby General Hospital (PMGH). DESIGN A retrospective analysis of treatment initiation in adults diagnosed with MDR/RR-TB (2018–2022) and outcomes for a cohort treated for MDR/RR-TB (2014-2019). We assessed the factors associated with LTFU using multivariate logistic regression. RESULTS Of 95 patients diagnosed with MDR/RR-TB at PMGH from 2018 to 2022, 21 (22%) were lost to follow-up before treatment. Of the 658 adults who initiated treatment for MDR/RR-TB at PMGH from 2014 to 2019, 161 (24%) were lost to follow-up during treatment. A higher proportion of patients on injectable-containing long regimens (110/404, 27%) were lost to follow-up than those on the all-oral regimen containing bedaquiline (13/66, 12%). Treatment loss to follow-up was associated with age (35–54 years age group: aOR 0.49, 95% CI 0.32–0.77; 55–75 years age group: aOR 0.42, 95% CI 0.19–0.90; compared to the 15–34 years age group), residence outside of NCD (aOR 1.79, 95% CI 1.04–3.06), and year of treatment initiation. CONCLUSION Pre-treatment LTFU requires programmatic focus. Shorter oral regimens and decentralised services may address the reasons for higher LTFU in younger people and people living outside NCD.
Subjects
Author keywords
Authors and institutions
- The Burnet Institute, Port Moresby, Papua New Guinea (PNG).
- The Burnet Institute, Melbourne, VIC, Australia.
- Port Moresby General Hospital, Port Moresby, PNG.
- University of Melbourne Department of Paediatrics, Royal Children's Hospital, Melbourne, VIC, Australia.
- National Department of Health, PNG.
- Gulf Provincial Health Authority.
Cite
APA
Charles, F., Lin, Y. D., Greig, J., Gurra, S., Morikawa, R., Graham, S. M., & Maha, A. (2024). Loss to follow-up among adults with drug-resistant TB in Papua New Guinea. Public Health Action, 14(3), 85-90. https://doi.org/10.5588/pha.24.0004
Vancouver
Charles F, Lin YD, Greig J, Gurra S, Morikawa R, Graham SM, et al. Loss to follow-up among adults with drug-resistant TB in Papua New Guinea. Public Health Action. 2024;14(3):85-90. doi:10.5588/pha.24.0004
BibTeX
@article{Charles2024,
author = {Charles, F and Lin, Y D and Greig, J and Gurra, S and Morikawa, R and Graham, S M and Maha, A},
title = {Loss to follow-up among adults with drug-resistant TB in Papua New Guinea},
journal = {Public Health Action},
year = {2024},
volume = {14},
number = {3},
pages = {85--90},
doi = {10.5588/pha.24.0004}
}
EUVIMED